David Tousley joins board of advisors at Madeira
This article was originally published in Scrip
Executive Summary
Madeira Therapeutics (US), a new drug development company specialising in paediatric pharmaceuticals, has appointed David Tousley to its board of advisors. Mr Tousley is the principal of Stratium Consulting Services, assisting companies with strategic and financial planning and management.